Analysts Offer Insights on Technology Companies: Maxlinear (MXL) and Cellebrite DI (CLBT)
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Maxlinear (MXL) and Cellebrite DI (CLBT) with bullish sentiments.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Maxlinear (MXL)
In a report released today, Richard Shannon from Craig-Hallum maintained a Buy rating on Maxlinear. The company’s shares closed last Thursday at $23.35.
According to TipRanks.com, Shannon is a top 25 analyst with an average return of
Currently, the analyst consensus on Maxlinear is a Moderate Buy with an average price target of $22.08, which is a -0.6% downside from current levels. In a report issued on April 13, TipRanks – Google also upgraded the stock to Buy with a $23.50 price target.
See the top stocks recommended by analysts >>
Cellebrite DI (CLBT)
Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on Cellebrite DI today. The company’s shares closed last Thursday at $12.71, close to its 52-week low of $10.25.
According to TipRanks.com, Rhee is a 5-star analyst with an average return of
Cellebrite DI has an analyst consensus of Strong Buy, with a price target consensus of $20.67, which is a 59.0% upside from current levels. In a report issued on April 15, William Blair also maintained a Buy rating on the stock.
Read More on MXL:
